Skip to content

Ingevity NGVT Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

Chemours logo
ChemoursCC
$7M
Innospec logo
InnospecIOSP
$0-100%
Westlake logo
WestlakeWLK
-$6M-20.0%
RPM International logo
RPM InternationalRPM
$0-100%
Celanese Corporation logo
Celanese CorporationCE
$48M+1,500%
Ceco Environmental logo
Ceco EnvironmentalCECO
$219K+1,360%

Other financials

Income statement

See full
Revenue$258.0M+4.1%
Gross profit$116.4M+4.0%
Net income$59.8M+192%
EPS (diluted)$1.66+196%

Balance sheet

See full
Cash & equivalents$95.4M+5.0%
Total debt$1.4B-9.0%
Total equity$38.9M-83.4%
Total assets$1.7B-19.7%

Cash flow

See full
Operating cash flow-$2.0M-108%
CapEx$10.3M+3.0%
Free cash flow-$12.3M-180%

Valuation

See full
Market cap$2.6B+73.9%

Profitability

See full
Gross margin39.3%+1.5pp
Net margin-10.6%-4.1pp
FCF margin20.3%+12.6pp

Returns & leverage

See full
Return on equity-93.5%+1.2pp
Debt / equity35.1×+28.7×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.

The official record: Ingevity’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ingevity's gain/loss on asset sales?
Ingevity (NGVT) reported gain/loss on asset sales of $55.6M in Q1 2026.
What does gain/loss on asset sales mean?
Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.